Ibrexafungerp - SCYNEXIS
At a glance
- Drug Originator Merck & Co; SCYNEXIS
- Drug Licenced by GSK; Jiangsu Hansoh Pharmaceutical; R-Pharm
- Drug Class Alkanes; Amines; Antifungals; Carboxylic acids; Ethers; Glycosides; Heterocyclic compounds; Pyridines; Small molecules; Triazoles; Triterpenes
- Mechanism of Action Beta-1,3-D glucan synthetase inhibitors
- USA Patent Applicants SCYNEXIS
- USA Patents 5
- NDAs 1
- International Patents 50

Disclaimer